These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 29997121)

  • 1. Transcriptome Assembly and Profiling of
    Kean R; Delaney C; Sherry L; Borman A; Johnson EM; Richardson MD; Rautemaa-Richardson R; Williams C; Ramage G
    mSphere; 2018 Jul; 3(4):. PubMed ID: 29997121
    [No Abstract]   [Full Text] [Related]  

  • 2. Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol.
    Srivastava V; Ahmad A
    PLoS One; 2020; 15(5):e0233102. PubMed ID: 32392266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms.
    Ramage G; Bachmann S; Patterson TF; Wickes BL; López-Ribot JL
    J Antimicrob Chemother; 2002 Jun; 49(6):973-80. PubMed ID: 12039889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal and anti-biofilm effects of 6-shogaol against Candida auris.
    Kim HR; Eom YB
    J Appl Microbiol; 2021 Apr; 130(4):1142-1153. PubMed ID: 32981148
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Romera D; Aguilera-Correa JJ; Gadea I; Viñuela-Sandoval L; García-Rodríguez J; Esteban J
    J Med Microbiol; 2019 Sep; 68(9):1353-1358. PubMed ID: 31271350
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.
    Mukherjee PK; Chandra J; Kuhn DM; Ghannoum MA
    Infect Immun; 2003 Aug; 71(8):4333-40. PubMed ID: 12874310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of efflux pump activity, biofilm formation, and immune escape by candidacidal geraniol in emerging superbug, Candida auris.
    Fatima T; Fatima Z; Hameed S
    Int Microbiol; 2023 Nov; 26(4):881-891. PubMed ID: 36847907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Analysis of
    Kim SH; Iyer KR; Pardeshi L; Muñoz JF; Robbins N; Cuomo CA; Wong KH; Cowen LE
    mBio; 2019 Jan; 10(1):. PubMed ID: 30696744
    [No Abstract]   [Full Text] [Related]  

  • 9. Candida auris Phenotypic Heterogeneity Determines Pathogenicity
    Brown JL; Delaney C; Short B; Butcher MC; McKloud E; Williams C; Kean R; Ramage G
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581078
    [No Abstract]   [Full Text] [Related]  

  • 10. Transcriptional Profiling of the Candida auris Response to Exogenous Farnesol Exposure.
    Jakab Á; Balla N; Ragyák Á; Nagy F; Kovács F; Sajtos Z; Tóth Z; Borman AM; Pócsi I; Baranyai E; Majoros L; Kovács R
    mSphere; 2021 Oct; 6(5):e0071021. PubMed ID: 34643421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
    Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutations in
    Rybak JM; Muñoz JF; Barker KS; Parker JE; Esquivel BD; Berkow EL; Lockhart SR; Gade L; Palmer GE; White TC; Kelly SL; Cuomo CA; Rogers PD
    mBio; 2020 May; 11(3):. PubMed ID: 32398311
    [No Abstract]   [Full Text] [Related]  

  • 13. Activities of nine antifungal agents against Candida auris biofilms.
    Chatzimoschou A; Giampani A; Meis JF; Roilides E
    Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris.
    Barreto TL; Rossato L; de Freitas ALD; Meis JF; Lopes LB; Colombo AL; Ishida K
    Int J Antimicrob Agents; 2020 Aug; 56(2):106049. PubMed ID: 32544569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms.
    Hashemi MM; Rovig J; Holden BS; Taylor MF; Weber S; Wilson J; Hilton B; Zaugg AL; Ellis SW; Yost CD; Finnegan PM; Kistler CK; Berkow EL; Deng S; Lockhart SR; Peterson M; Savage PB
    J Antimicrob Chemother; 2018 Jun; 73(6):1537-1545. PubMed ID: 29635279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenylyl Cyclase and Protein Kinase A Play Redundant and Distinct Roles in Growth, Differentiation, Antifungal Drug Resistance, and Pathogenicity of
    Kim JS; Lee KT; Lee MH; Cheong E; Bahn YS
    mBio; 2021 Oct; 12(5):e0272921. PubMed ID: 34663094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome Analysis of Human Dermal Cells Infected with Candida auris Identified Unique Pathogenesis/Defensive Mechanisms Particularly Ferroptosis.
    Fayed B; Shakartalla SB; Sabbah H; Dalle H; Tannira M; Senok A; Soliman SSM
    Mycopathologia; 2024 Jul; 189(4):65. PubMed ID: 38990436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen.
    Dekkerová J; Lopez-Ribot JL; Bujdáková H
    Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):101-108. PubMed ID: 30327897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrogation of Triazole Resistance upon Deletion of
    Rybak JM; Doorley LA; Nishimoto AT; Barker KS; Palmer GE; Rogers PD
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718246
    [No Abstract]   [Full Text] [Related]  

  • 20. What do we know about the biology of the emerging fungal pathogen of humans Candida auris?
    Bravo Ruiz G; Lorenz A
    Microbiol Res; 2021 Jan; 242():126621. PubMed ID: 33096325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.